Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04897061 · ClinicalTrials.gov registry record
Caregiver Support and Post-operative Convalescence
A clinical trial of Pelvic Organ Prolapse, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 103
- Enrollment target
- 1
- Study location
NCT04897061: Completed study of Pelvic Organ Prolapse, sponsored by Icahn School of Medicine at Mount Sinai.
NCT04897061 is a study of Pelvic Organ Prolapse that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 103 participants, below the 143-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04897061, a study of Pelvic Organ Prolapse, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective cohort study designed to investigate the impact of home caregiver support on post-operative convalescence in patients undergoing same day discharge after major urogynecologic surgery. Questionnaires assessing post-operative convalescence will be distributed at several time points after surgery. The main hypothesis is that increased caregiver support in the post-operative period will improve post-operative convalescence of patients undergoing major urogynecologic surgery.
Primary Outcome
Changes in Quality of Recovery 15 (QOR-15) scores based on a priori caregiver characteristics on post-operative days 3, 7, 14 and 28. QOR-15 is a 15 item instrument, full score range from 0 to 150, with higher score indicating better health outcomes.
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2021-05-24 |
| Est. Completion | 2022-11-01 |
What the finished NCT04897061 record still lists
NCT04897061 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 143-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 0 interventions.
NCT04897061 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04897061 about?
NCT04897061 is a clinical study titled "Caregiver Support and Post-operative Convalescence". This is a prospective cohort study designed to investigate the impact of home caregiver support on post-operative convalescence in patients undergoing same day discharge after major urogynecologic surgery. Questionnaires assessing post-operative convalescence will be distributed at several time poin...
What is the current status of trial NCT04897061?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2021-05-24. Estimated completion is 2022-11-01.
What conditions does trial NCT04897061 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse.
Who is sponsoring clinical trial NCT04897061?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04897061 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04897061's enrollment target sits among peer trials
103 21st of 40 higher than 20 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Centered Surgery - Preoperative Counseling and Patient Satisfaction
RECRUITING
-
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
RECRUITING
-
Pessary Experience Study
RECRUITING
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI